News
11-02-2007, 02:40 PM
Researchers at the Virginia Commonwealth University Massey Cancer Center have identified the enzyme sphingosine kinase 2 as a possible new therapeutic target to improve the efficacy of chemotherapy for colon and breast cancer.
More... (http://www.news-medical.net/?id=32105)
More... (http://www.news-medical.net/?id=32105)